Institutional Ownership Bolt Biotherapeutics, Inc. (BOLT)
This table provides information about the institutional ownership of Bolt Biotherapeutics, Inc. (BOLT). We have compiled data on the 33 institutions that hold shares in the stock, with a total of 19.1 Million shares, which have been reported (via 13F filing form) to have a value of $10.5 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Assenagon Asset Management S.A.
|
Oct 23, 2024 Q3 2024 |
20,785
shares
|
$11,431
0.0% of portfolio
|
Q3 2024
Reduced 39.73%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Nov 13, 2024 Q3 2024 |
17,355
shares
|
$9,545
0.0% of portfolio
|
Q3 2024
Added 15.7%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
6,000
shares
|
$3,300
0.0% of portfolio
|
Q3 2024
Added 855.41%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Dec 26, 2024 Q3 2024 |
914
shares
|
$502
0.0% of portfolio
|
Q3 2024
Added 8.81%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
184
shares
|
$101
0.0% of portfolio
|
Q2 2024
Reduced 96.68%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
139
shares
|
$76
0.0% of portfolio
|
Q2 2023
Reduced 5.44%
|
|
|
Salem Investment Counselors Inc
Winston Salem, NC |
Oct 15, 2024 Q3 2024 |
40
shares
|
$22
0.0% of portfolio
|
Q1 2022
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|